SIRT1 and chronic kidney disease: Modulating endogenous antioxidant and metabolic pathways such as AMPK and SIRT1 provides a broader therapeutic framework, particularly because phosphate excess is a major trigger of oxidative stress, mitochondrial dysfunction, and endothelial injury in CKD.